TrialOncotarget2022

Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score-matched analysis of E7438-G000-101 trial outcomes.

David G Proudman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.